Literature DB >> 23474369

Effects of nicotine on emotional distraction of attentional orienting: evidence of possible moderation by dopamine type 2 receptor genotype.

Jonathan J Hammersley1, Adam Rzetelny, David G Gilbert, Norka E Rabinovich, Stacey L Small, Jodi I Huggenvik.   

Abstract

INTRODUCTION: Growing evidence suggests that attentional bias to, and distraction by, emotional stimuli may moderate affective states and motivation for nicotine and other drug use.
METHODS: The present study assessed the effects of nicotine and dopamine receptor genotype on distraction by emotional pictures, during a modified spatial attention task, in 46 overnight-deprived smokers.
RESULTS: Relative to placebo, 14mg nicotine patch produced shorter overall reaction times (RTs) and individuals with two dopamine type 2 receptor (DRD2) A2 alleles exhibited the greatest RT benefit from nicotine following emotionally negative pictures after the longest cue-target delay (800ms), but benefitted least from nicotine following positive pictures after the shortest delay (400ms). In contrast, at the shortest delay, A1 carriers did not benefit from nicotine following emotionally negative pictures but did following positive ones.
CONCLUSIONS: These genetic differences in the effects of nicotine on attention immediately following emotionally positive versus negative stimuli may reflect differential excitatory and inhibitory transmitter processes related to approach (reward) and avoidance (punishment) sensitivities of dopamine-related neural networks that support positive and negative affect.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474369      PMCID: PMC4866493          DOI: 10.1016/j.pbb.2013.02.017

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  39 in total

1.  Association of serotonin transporter genotype with selective processing of smoking-related stimuli in current smokers and ex-smokers.

Authors:  Marcus R Munafò; Elaine C Johnstone; Bundy Mackintosh
Journal:  Nicotine Tob Res       Date:  2005-10       Impact factor: 4.244

2.  A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.

Authors:  Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

3.  Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.

Authors:  M R Spitz; H Shi; F Yang; K S Hudmon; H Jiang; R M Chamberlain; C I Amos; Y Wan; P Cinciripini; W K Hong; X Wu
Journal:  J Natl Cancer Inst       Date:  1998-03-04       Impact factor: 13.506

4.  Personality and the inheritance of smoking behavior: a genetic perspective.

Authors:  A C Heath; P A Madden; W S Slutske; N G Martin
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

Review 5.  Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Authors:  K Blum; E R Braverman; J M Holder; J F Lubar; V J Monastra; D Miller; J O Lubar; T J Chen; D E Comings
Journal:  J Psychoactive Drugs       Date:  2000-11

Review 6.  Nicotinic acetylcholine involvement in cognitive function in animals.

Authors:  E D Levin; B B Simon
Journal:  Psychopharmacology (Berl)       Date:  1998-08       Impact factor: 4.530

7.  Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Authors:  Elaine C Johnstone; Patricia L Yudkin; Kate Hey; Sarah J Roberts; Sarah J Welch; Michael F Murphy; Siân E Griffiths; Robert T Walton
Journal:  Pharmacogenetics       Date:  2004-02

8.  Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation.

Authors:  J H Powell; A D Pickering; L Dawkins; R West; J F Powell
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

9.  Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol.

Authors:  D G Gilbert; C J Meliska; C L Williams; R A Jensen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch.

Authors:  David G Gilbert; Yantao Zuo; Norka E Rabinovich; Hege Riise; Rachel Needham; Jodi I Huggenvik
Journal:  J Abnorm Psychol       Date:  2009-05
View more
  4 in total

1.  Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms.

Authors:  Stefan Ahrens; Sebastian Markett; Thomas P K Breckel; Oliver Behler; Martin Reuter; Christiane M Thiel
Journal:  Psychopharmacology (Berl)       Date:  2015-02-03       Impact factor: 4.530

2.  Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity.

Authors:  Jonathan J Hammersley; David G Gilbert; Adam Rzetelny; Norka E Rabinovich
Journal:  Pharmacol Biochem Behav       Date:  2016-07-25       Impact factor: 3.533

3.  Nicotine reduces distraction under low perceptual load.

Authors:  Oliver Behler; Thomas P K Breckel; Christiane M Thiel
Journal:  Psychopharmacology (Berl)       Date:  2014-10-11       Impact factor: 4.530

4.  Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes.

Authors:  Thomas P K Breckel; Carsten Giessing; Anja Gieseler; Sarah Querbach; Martin Reuter; Christiane M Thiel
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.